Neuropsychiatric Disease and Treatment (Dec 2020)
Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function
Abstract
Li-Hong Pan,1,* Ming Qian,1,* Weihua Qu,2 Qin Tang,2 Yuzhong Yan3 1Department of Psychiatry, Shanghai Pudong Nanhui Mental Health Center, Shanghai, People’s Republic of China; 2Department of Clinical Laboratory, Shanghai Prison General Hospital, Shanghai, People’s Republic of China; 3Department of Research, Shanghai University of Medicine and Health Science Affiliated Zhoupu Hospital, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yuzhong Yan Email [email protected]: Serum levels of C-reactive protein (CRP) were measured in patients with deficit schizophrenia (DS) to confirm the association between CRP level and cognitive performance and to determine whether CRP was a new biological indicator with the potential clinical applications in DS patients.Methods: Three independent samples [41 DS and 50 non-deficit schizophrenia (NDS) and 30 sex- and age-matched healthy controls (HCs)] were recruited in our study. Serum CRP levels were measured by immunofluorescence. The Positive and Negative Syndrome Scale (PANSS) and alternative forms of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) were also assessed. And the relationships between serum CRP levels and both PANSS and RBANS scores were finally analyzed.Results: The results of serum CRP level were showed significantly different among the three groups and increased from the HCs to NDS patients to DS patients. There were also significant differences in the cognitive subdomain analyses among the three groups. Serum CRP levels were found positively correlated with total and negative PANSS scores, and showed negatively correlated with overall cognitive test scores in the DS samples.Conclusion: Serum C-reactive protein levels and their association with cognitive performance were different between deficit schizophrenia and non-deficit schizophrenia samples, and higher serum CRP level was associated with worse cognitive performance in the DS patients. The results indicated that CRP could be a potential biomarker, and DS could be a distinct subset of schizophrenia.Keywords: schizophrenia, deficit schizophrenia, C-reactive protein, inflammation, cognitive impairment
